Hostname: page-component-54dcc4c588-sq2k7 Total loading time: 0 Render date: 2025-09-16T08:06:10.212Z Has data issue: false hasContentIssue false

Age-Related Cognitive Decline in Substance Use Disorder: Impact of Prolonged Substance Consumption

Published online by Cambridge University Press:  26 August 2025

C. Roncero*
Affiliation:
Health Science, European University Miguel de Cervantes, Valladolid Psychiatry, University of Salamanca
D. Remón-Gallo
Affiliation:
Psychiatry, University of Salamanca Neurosicence, Institute of biomedicine (IBSAL), Salamanca, Spain
L. Aguilar
Affiliation:
Psychiatry, University of Salamanca Neurosicence, Institute of biomedicine (IBSAL), Salamanca, Spain
A. Alvarez-Navares
Affiliation:
Psychiatry, University of Salamanca Neurosicence, Institute of biomedicine (IBSAL), Salamanca, Spain
M. Peña
Affiliation:
Health Science, European University Miguel de Cervantes, Valladolid
A. Fernandez-Parra
Affiliation:
Health Science, European University Miguel de Cervantes, Valladolid
J. Perez
Affiliation:
Psychiatry, University of Salamanca Neurosicence, Institute of biomedicine (IBSAL), Salamanca, Spain
A. Gonzalez-Sanchez
Affiliation:
Neurosicence, Institute of biomedicine (IBSAL), Salamanca, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The consumption of alcohol, cannabis, cocaine, or heroin causes alterations in the central nervous system, affecting mood, perception, and behaviour. Despite the harmful effects of these substances, they remain widely used. Younger individuals tend to consume cannabis and cocaine, while older adults more commonly use alcohol and prescription medications. Ageing brings changes in consumption patterns and has both physical and mental health consequences

Objectives

This study aims to analyze how age influences the clinical characteristics of patients with Substance Use Disorder (SUD), comparing differences between older and younger users.

Methods

A total of 297 SUD patients participated in this study. They were divided into two groups: those aged 55 and older (G1) n= 88, and those younger than 55 (G2) n= 209. The SF-36 questionnaire was used to assess quality of life, the BIS-11 for impulsivity, the ASRS v1.1 for ADHD, the STAI-R for anxiety, and the AQ for autistic traits. All participants provided informed consent, and the study adhered to ethical guidelines.

Results

G1 showed better social functioning (SF-36) but a significant physical decline compared to G2. G1 also demonstrated lower levels of impulsivity (BIS-11), aggression, anxiety (STAI-R), and ADHD symptoms (ASRS), though higher autistic traits (AQ) were observed in G1.

Conclusions

Ageing reduces impulsivity, aggression, anxiety, and ADHD symptoms in individuals with SUD, but worsens physical health and may increase social isolation and autistic traits. These findings underscore the need to adapt SUD treatments according to age, addressing both physical and psychosocial challenges specific to each group.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.